The role of cytochrome P450 2D6 in the metabolism of moclobemide

POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN

1977 • 1,196 citations

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

1988 • 717 citations

Polymorphic dextromethorphan metabolism: Co-segregation of oxidative O-demethylation with debrisoquin hydroxylation

1985 • 386 citations

MEDICAL NEMESIS

1974 • 377 citations

Human cytochromes P450: problems and prospects

1992 • 364 citations

The role of individual human cytochrpmes P450 in drug metabolism and clinical response

1992 • 246 citations

Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.

1989 • 195 citations

Human cytochrome P-450 enzymes

1992 • 157 citations

The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes.

1994 • 101 citations

Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: A panel study*

1995 • 98 citations

Monoamine oxidase : basic and clinical aspects

1993 • 96 citations

The pharmacogenetics of the selective serotonin reuptake inhibitors

1993 • 90 citations

Amitriptyline metabolism: Relationship to polymorphic debrisoquine hydroxylation

1983 • 70 citations

Pharmacokinetics of dextromethorphan and dextrorphan: a single dose comparison of three preparations in human volunteers.

1987 • 68 citations

Biotransformation of moclobemide in humans

1990 • 66 citations

An update of recent moclobemide interaction data

1993 • 63 citations

Clinical Pharmacokinetics of the Monoamine Oxidase-A Inhibitor Moclobemide*

1995 • 62 citations

Interactions of moclobemide with concomitantly administered medication: evidence from pharmacological and clinical studies

1992 • 56 citations

Determination of the new monoamine oxidase inhibitor moclobemide and three of its metabolites in biological fluids by high-performance liquid chromatography

1987 • 51 citations

Inhibition of hepatic P-450 isoenzymes by serotonin selective reuptake inhibitors: in vitro and in vivo findings and their implications for patient care.

1994 • 50 citations

Clinical implications of genetic polymorphism in drug metabolism.

1994 • 50 citations

Clinical consequences of polymorphic drug oxidation

1991 • 34 citations

Relevance of genetic polymorphism in drug metabolism in the development of new drugs

1989 • 33 citations

Moclobemide treatment causes a substantial rise in the sparteine metabolic ratio. Danish University Antidepressant Group.

1993 • 30 citations

Debrisoquine oxidative phenotyping and psychiatric drug treatment

1989 • 28 citations

Influence of food on the tyramine pressor effect during chronic moclobemide treatment of healthy volunteers

1992 • 22 citations

Cimetidine alters the disposition kinetics of the monoamine oxidase-A inhibitor moclobemide

1991 • 20 citations

Role of cytochrome P4502D6 in the metabolism of brofaromine

1993 • 19 citations

Comparison of the pharmacokinetics of moclobemide in poor and efficient metabolizers of debrisoquine

1990 • 16 citations

Cytochromes in Psychopharmacology

1994 • 12 citations